A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori.

MLA

Sapmaz, Ferdane, et al. “A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter Pylori.” American Journal of Therapeutics, vol. 24, no. 4, July 2017, pp. e393–98. EBSCOhost, https://doi.org/10.1097/MJT.0000000000000316.

APA

Sapmaz, F., Kalkan, I. H., Atasoy, P., Basyigit, S., & Guliter, S. (2017). A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori. American Journal of Therapeutics, 24(4), e393–e398. https://doi.org/10.1097/MJT.0000000000000316

Chicago

Sapmaz, Ferdane, Ismail H Kalkan, Pinar Atasoy, Sebahat Basyigit, and Sefa Guliter. 2017. “A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter Pylori.” American Journal of Therapeutics 24 (4): e393–98. doi:10.1097/MJT.0000000000000316.